Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies Meeting Abstract
| Authors: | Rozner, R. N.; Freites-Martinez, A.; Shapiro, J.; Geer, E. B.; Goldfarb, S.; Lacouture, M. E. |
| Abstract Title: | Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies |
| Meeting Title: | 77th Annual Meeting of the American Academy of Dermatology (AAD) |
| Journal Title: | Journal of the American Academy of Dermatology |
| Volume: | 81 |
| Issue: | 4 Suppl. 1 |
| Meeting Dates: | 2019 Mar 1-5 |
| Meeting Location: | Washington, DC |
| ISSN: | 0190-9622 |
| Publisher: | Mosby Elsevier |
| Date Published: | 2019-10-01 |
| Start Page: | AB1 |
| Language: | English |
| ACCESSION: | WOS:000482195000002 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jaad.2019.06.045 |
| Notes: | Meeting Abstract: 8059 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
